The global aesthetic lasers market is forecast to reach $11.1 billion by 2036, reflecting compound annual growth rates that underscore the durability of device-driven revenue in medical aesthetics. The projection encompasses RF microneedling, fractional lasers, HIFU platforms, and diode systems—the core modalities that practices use to differentiate from toxin-and-filler competitors and build recurring patient visits.
Devices & Tech
Aesthetic Lasers Market Projected to Hit $11.1B by 2036
Double-digit CAGR signals sustained device demand as RF, HIFU, and fractional CO2 consolidate practice economics.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
Aesthetic lasers are projected to reach $11.1B by 2036—a market that rewards practices with capital for multi-modality infrastructure.
For practice owners, the growth trajectory validates device acquisition as a capital-efficient move. Lasers and energy devices command higher per-treatment margins than injectables and drive patient loyalty through multi-session protocols. The market expansion also signals consolidation: larger platforms like InMode, Cutera, and Lumenis will continue absorbing smaller competitors, narrowing the field of viable acquisition targets for practices seeking turnkey solutions.
Source: original report ↗
Frequently asked questions
What is the projected size of the aesthetic lasers market by 2036?
The global aesthetic lasers market is forecast to reach $11.1 billion by 2036, driven by double-digit compound annual growth rates. This growth reflects sustained demand for device-driven revenue across RF microneedling, fractional lasers, HIFU platforms, and diode systems.
Which aesthetic laser companies are consolidating the market?
Larger platforms like InMode, Cutera, and Lumenis are continuing to absorb smaller competitors, narrowing the field of viable acquisition targets for practices seeking turnkey solutions.
Why should medspa owners invest in aesthetic laser devices?
Lasers and energy devices command higher per-treatment margins than injectables and drive patient loyalty through multi-session protocols, making device acquisition a capital-efficient move that differentiates practices from toxin-and-filler competitors.
What are the main aesthetic laser modalities driving market growth?
The core modalities fueling growth are RF microneedling, fractional lasers, HIFU platforms, and diode systems—technologies that enable practices to build recurring patient visits and establish device-driven revenue streams.
How do aesthetic devices compare to injectables for practice profitability?
Aesthetic lasers and energy devices generate higher per-treatment margins than injectables and encourage multi-session treatment protocols, creating stronger patient loyalty and more predictable recurring revenue for practices.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.